Ray Therapeutics Funding & Investors

Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.

raytherapeutics.com

Total Amount Raised: $114,000,000

Ray Therapeutics Funding Rounds

Series A
$100,000,000
May 15, 2023
Series A Investors
Novo Holdings
4BIO Capital
Wu Capital
Deerfield Management
Norwest Venture Partners
MRL Ventures Fund
Grant
$4,000,000
Apr 26, 2022
Grant Investors
California Institute for Regenerative Medicine
Grant
$4,000,000
Nov 12, 2023
Grant Investors
California Institute for Regenerative Medicine
Seed
$6,000,000
Jan 3, 2022
Seed Investors
4BIO Capital

Funding info provided by Diffbot.